TC BioPharm starts clinical study in cancer patients

Oncology centres in Glasgow and Edinburgh commence recruitment of skin, lung and kidney cancer patients Novel therapy ‘ImmuniCell®’ uses ‘killer cells’ to target the tumour Biotechnology company TC BioPharm Ltd (TCB) has today announced its MHRA-approved (Medicines and Healthcare Regulatory Agency) clinical study has commenced, treating patients suffering from several different tumour types including melanoma, […]

Read More

TC BioPharm granted approval to treat cancer patients

Trials to Commence in October at the Beatson West of Scotland Cancer Centre in Glasgow Melanoma, Lung and Kidney Cancer Patients First to be Treated Biotechnology company TC BioPharm Ltd (TCB) has today announced it has been granted a Clinical Trial Authorisation (CTA) by UK regulators to treat cancer patients with its novel cell therapy […]

Read More

Investing Women appoint Director to TC BioPharm Board

Oil and Gas Entrepreneur Adds Business Experience To Cancer Treatment Firm Female angel investment group Investing Women has appointed oil and gas entrepreneur Lorraine Porter as non-executive director to the board of biotechnology company TC BioPharm. Investing Women led the recent £1.2 million equity and grand funding which has allowed Lanarkshire-based TC BioPharm (TCB) to […]

Read More

TC BioPharm Ltd raises £1.2m to commence treatment of UK cancer patients

Biotechnology company TC BioPharm Ltd (TCB) announced today it has raised £1.18 million in equity and grant funding to treat UK-based patients with melanoma, lung and kidney cancer. Investing Women, Scotland’s only female angel group, marked its first major investment in leading the £680,000 investment with support from Scottish Investment Bank and WH Partnership. The […]

Read More

TC BioPharm Ltd gets green light for cancer trial

TC BioPharm (TCB) has been handed the right to become the only biotechnology company outside Japan to trial immunotherapy to treat patients with cancer. The company has received a licence from the Medicines Healthcare Products Regulatory Agency (MHRA) to produce human cell therapy products at its clinical manufacturing facility in Lanarkshire. The process is understood […]

Read More